Bandingkan Harga & Kinerja Eterindo Wahanatama Tbk (ETWA) vs Indofarma Tbk. (INAF)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Eterindo Wahanatama Tbk dan Indofarma Tbk.: Eterindo Wahanatama Tbk diperdagangkan di Rp70 (kapitalisasi pasar 326,81 M), sedangkan Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M). Perbedaan utamanya: Indofarma Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| ETWA | INAF | |
|---|---|---|
Kapitalisasi Pasar | 326,81 M | 390,51 M |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Eterindo Wahanatama Tbk
PT Eterindo Wahanatama Tbk or Eterindo is the parent company to midstream specialty chemical companies, interrelated by ownership and through both vertical and horizontal integration. Eterindo has established itself as one of the largest producers of specialty in South East Asia. The products are used as raw material in the production of paints, coatings, adhesives and similar consumer product realm. The breadth of its range gives Eterindo a distinct edge over its competitors.Presently, Eterindo is among the largest producers of plasticizers, an important raw material for producing cables, footwear, tyres and other basic consumer goods, near to one daily usage in life. Modern production facilities, state of the art technology and a highly trained and dedicated labour force means Eterindo companies will continue to offer high quality at competitive prices, to customers at home and overseas. In recognition of its technical achievement, Eterindo has been awarded ISO 9002 certification. Strategic partnership have been formed with multinationals, including Mitsui & Co. Ltd. Of Japan, Kyowa Hakko Kogyo Co. Ltd., Mitsui Bussan Solvent & Coating Co., Ltd., Daewoo Group of Korea and state owned company PT Petrokimia Gresik.
Selengkapnya di halaman ETWA →Tentang Indofarma Tbk.
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Selengkapnya di halaman INAF →
